Drug resistance mutations after the first 12 months on antiretroviral therapy and determinants of virological failure in Rwanda-Reference-Cited by-同舟云学术

Drug resistance mutations after the first 12 months on antiretroviral therapy and determinants of virological failure in Rwanda

Published:2016-06-13 Issue:7 Volume:21 Page:928-935
ISSN:1360-2276
Container-title:Tropical Medicine & International Health
language:en
Short-container-title:Trop Med Int Health

Author:

Ndahimana Jean d'Amour¹,Riedel David J.²,Mwumvaneza Mutagoma¹,Sebuhoro Dieudone¹,Uwimbabazi Jean Claude³,Kubwimana Marthe¹,Mugabo Jules⁴,Mulindabigwi Augustin¹,Kirk Catherine⁵,Kanters Steve⁶⁷,Forrest Jamie I.⁶⁷,Jagodzinski Linda L.⁸,Peel Sheila A.⁸,Ribakare Muhayimpundu¹,Redfield Robert R.²,Nsanzimana Sabin¹⁹

Affiliation:

1. HIV/AIDS Division Rwanda Biomedical Center Kigali Rwanda

2. Institute of Human Virology and Division of Infectious Diseases University of Maryland Baltimore MD USA

3. Rwanda Biomedical Center Reference Laboratory Kigali Rwanda

4. World Health Organization Kigali Rwanda

5. Partners in Health/Inshuti Mu Buzima Kigali Rwanda

6. School of Population and Public Health University of British Columbia Vancouver BC Canada

7. Global Evaluative Sciences Vancouver BC Canada

8. Walter Reed Army Institute of Research Silver Spring MD USA

9. Swiss Tropical and Public Health Institute University of Basel and Basel Institute for Clinical Epidemiology and Biostatistics Basel Switzerland

Funder

World Health Organization

Henry M. Jackson Foundation

U.S. Department of Defense

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,Parasitology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tmi.12717

Reference27 articles.

1. Life Expectancy of Persons Receiving Combination Antiretroviral Therapy in Low-Income Countries: A Cohort Analysis From Uganda

2. Life expectancy among HIV-positive patients in Rwanda: a retrospective observational cohort study

3. NsanzimanaS.Rwanda Experience towards HIV treatment as prevention. In: International Treatment as Prevention Workshop.Vancouver Canada 2013.

4. Emerging HIV-1 drug resistance after roll-out of antiretroviral therapy in sub-Saharan Africa

5. Prevalence and Virologic Consequences of Transmitted HIV-1 Drug Resistance in Uganda

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of ART effects and drug resistance in adult HIV/AIDS patients in Meigu County, Liangshan Prefecture, China;BMC Infectious Diseases;2024-02-01

2. Prevalence and predictors of virologic failure among HIV patients on antiretroviral therapy in Makueni County: a cross-sectional study;F1000Research;2023-07-25

3. Determinants of virological failure in HIV1 infected patients followed in a third-level hospital Abidjan, Cote d’Ivoire;Indian Journal of Microbiology Research;2023-07-15

4. Factors Associated With Delayed and Late Initiation of Antiretroviral Therapy Among Patients With HIV in Beijing, China, 2010–2020;International Journal of Public Health;2023-06-21

5. Failure to Attain HIV Viral Suppression After Intensified Adherence Counselling—What Can We Learn About Its Factors?;Infection and Drug Resistance;2023-03